Company profile: IONIQ Sciences
1.1 - Company Overview
Company description
- Provider of solutions for early detection of multiple cancers to improve survivability and reduce healthcare costs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IONIQ Sciences
BiPar Sciences
HQ: United States
Website
- Description: Provider of PARP inhibitor-based cancer therapies, developing BSI-201, an experimental PARP inhibitor in mid-stage trials for advanced breast cancer, ovarian cancer, and other tumors; based in Brisbane, CA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BiPar Sciences company profile →
Nativis
HQ: United States
Website
- Description: Provider of therapeutic modalities in development for the treatment of serious disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nativis company profile →
Intera Oncology
HQ: United States
Website
- Description: Provider of hepatic artery infusion (HAI) therapy and liver-directed chemotherapy delivery for colorectal cancer and cholangiocarcinoma patients, offering the Intera 3000 HAI pump, Cerona Therapeutics Floxuridine for Injection, USP, and related products (heparinized saline, saline, bacteriostatic water); acquired Oncology/Neuromodulation Drug Delivery products from Johnson & Johnson.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intera Oncology company profile →
Immunomic Therapeutics
HQ: United States
Website
- Description: Provider of lysosomal associated membrane protein-based immunotherapies and vaccines via its UNITE platform, leveraging natural biochemistry to elicit broad immune responses. Pipeline includes ITI-1000 (autologous dendritic cell therapy for glioblastoma), ITI-1001 (off-the-shelf CMV-targeting GBM immunotherapy), ITI-3000 (plasmid DNA vaccine for Merkel cell carcinoma), ITI-1771 (for CMV-driven cancers), and ITI-5000 (saRNA vaccine for TNBC).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunomic Therapeutics company profile →
Immunis AI
HQ: United States
Website
- Description: Provider of non-invasive, blood-based Active Surveillance Tests for active surveillance and early detection of diseases, initially validated for prostate cancer with future applications in other urological cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunis AI company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IONIQ Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IONIQ Sciences
2.2 - Growth funds investing in similar companies to IONIQ Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IONIQ Sciences
4.2 - Public trading comparable groups for IONIQ Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →